Lessons From Europe’s Loss of Biopharma Leadership, and Its Attempts to Recover (opens in new tab)

Please join ITIF for an expert panel discussion on what Europe’s experience reveals about the risks of undermining biopharmaceutical innovation, how policy choices shape R&D investment and competitiveness, and what steps U.S. policymakers should take to sustain American leadership in life sciences.